Soleno Therapeutics (SLNO) · page 368 of 415
The slide highlights the physician's skepticism and the administrative hurdles faced with the drug Vykat.
Activist deck · nominee_bio · introduce_nominees · dense density
Slide locked Sign in to view
Slide schematic 7/7
callout 1/1 paragraph 2/2 quote 2/2 source-note 1/1 title 1/1
Components 7
primary paragraph paragraph testimonial testimonial source-note headline
Tools 2
Audience Definition slide · 70%
PWS endocrinologist #5: Division Chief for pediatric endocrinology at a major academic center who sees 20-25 PWS patients annually.
Authority Bias slide · 60%Q: 'Have you submitted paperwork for a bunch of patients already?' A: 'I have, and it's all pending because it's a new drug.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.